Literature DB >> 14734748

The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.

Taku Kambayashi1, Jennifer R Kraft-Leavy, Joseph G Dauner, Barbara A Sullivan, Oskar Laur, Peter E Jensen.   

Abstract

The MHC class Ib molecule Qa-1 is the primary ligand for mouse CD94/NKG2A inhibitory receptors expressed on NK cells, in addition to presenting Ags to a subpopulation of T cells. CD94/NKG2A receptors specifically recognize Qa-1 bound to the MHC class Ia leader sequence-derived peptide Qdm. Qdm is the dominant peptide loaded onto Qa-1 under physiological conditions and this peptide has an optimal sequence for binding to Qa-1. Peptide dissociation experiments demonstrated that Qdm dissociates from soluble or cell surface Qa-1(b) molecules with a t(1/2) of approximately 1.5 h at 37 degrees C. In comparison, complexes of an optimal peptide (SIINFEKL) bound to the MHC class Ia molecule H-2K(b) dissociated with a t(1/2) in the range from 11 to 31 h. In contrast to K(b), the stability of cell surface Qa-1(b) molecules was independent of bound peptides, and several observations suggested that empty cell surface Qa-1(b) molecules might be unusually stable. Consistent with the rapid dissociation rate of Qdm from Qa-1(b), cells become susceptible to lysis by CD94/NKG2A(+) NK cells under conditions in which new Qa-1(b)/Qdm complexes cannot be continuously generated at the cell surface. These results support the hypothesis that Qa-1 has been selected as a specialized MHC molecule that is unable to form highly stable peptide complexes. We propose that the CD94/NKG2A-Qa-1/Qdm recognition system has evolved as a rapid sensor of the integrity of the MHC class I biosynthesis and Ag presentation pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734748     DOI: 10.4049/jimmunol.172.3.1661

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells.

Authors:  Hye-Jung Kim; Harvey Cantor
Journal:  Semin Immunol       Date:  2011-12       Impact factor: 11.130

2.  Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide.

Authors:  Nora E Renthal; Paula A Guidry; Sharmila Shanmuganad; William Renthal; Iwona Stroynowski
Journal:  Immunogenetics       Date:  2010-10-22       Impact factor: 2.846

3.  Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.

Authors:  Lili Chen; Eduardo Reyes-Vargas; Hu Dai; Hernando Escobar; Brant Rudd; Jared Fairbanks; Alexander Ho; Mathew F Cusick; Attila Kumánovics; Julio Delgado; Xiao He; Peter E Jensen
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

Review 4.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

5.  Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein.

Authors:  Yi Xu; Samiksha Wasnik; David J Baylink; Edmundo Carreon Berumen; Xiaolei Tang
Journal:  J Vis Exp       Date:  2017-12-20       Impact factor: 1.355

6.  An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus.

Authors:  Lili Chen; David C Jay; Jared D Fairbanks; Xiao He; Peter E Jensen
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

Review 7.  γδ T cell receptor ligands and modes of antigen recognition.

Authors:  Eric Champagne
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-02-06       Impact factor: 4.291

8.  PFA-fixed Hsp60sp-loaded dendritic cells as a vaccine for the control of mouse experimental allergic encephalomyelitis.

Authors:  Feng Liu; Hui Zheng; Yuanyuan Qi; Xue Wang; Jianjun Yang; Miaomiao Han; Han Zhang; Hong Jiang
Journal:  Cell Mol Immunol       Date:  2013-12-30       Impact factor: 11.530

9.  The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.

Authors:  Cláudia C Oliveira; Peter A van Veelen; Bianca Querido; Arnoud de Ru; Marjolein Sluijter; Sandra Laban; Jan W Drijfhout; Sjoerd H van der Burg; Rienk Offringa; Thorbald van Hall
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

Review 10.  The nonclassical immune surveillance for ERAAP function.

Authors:  Jian Guan; Josiah David Peske; Joshua A Taylor; Nilabh Shastri
Journal:  Curr Opin Immunol       Date:  2021-06-05       Impact factor: 7.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.